Blood test diagnosis of Parkinson's is expected next year

a Norwegian biomedical company says it will test Parkinson's disease by finding a test that can be used to diagnose Parkinson's disease through a simple blood test, and ahospital in the United States
will be the first to test it next yearParkinson's disease is a common neurological disorderdisease, mainly affecting the elderly, mostly after the age of 60Its symptoms aresuch asof the hand at rest, involuntary tremor of thehead or mouth, stiff ness
in the muscles, slowofmovement, and disorders of posture balance,cause the patient to live without self-careSo far
, the cause ofprimary Parkinson's disease is still not fully clear
there is no cure for Parkinson's diseaseThe Daily Telegraph reported22the study was funded by actor Michael Fox,he was diagnosed with Parkinson's disease in 1991 at the age of 30He suggested that early diagnosis of Parkinson's disease could be achieved by detecting chemical changes in the blood and finding genetic changes affected by the conditionResearch by The Norwegian company DiaGenic has found that Parkinson's disease causes chemical changes in the blood and affects 500 genesThey found tests that confirmed these chemical changes through blood testsAhospital in Boston, Massachusetts
has collected blood samples from 300 patients to test new testsDiaGenic says it hopes to register a patent for the new test as soon as possible so doctors can apply it by the end of next yearLast year, DiaGenic announced that it had discovered new blood tests that could diagnose Alzheimer's disease earlyAccording to statistics, the number of people living with Parkinson's disease in the world has exceeded 4 million Medical experts generally agree that the fight against Parkinson's disease can only benefit early if is detected early and treated early